Page 90 - 南京医科大学学报自然科学版
P. 90
第42卷第6期
·842 · 南 京 医 科 大 学 学 报 2022年6月
[8] HABURCHAK D R,ALCHREIKI M. Inpatients with‘un⁃ [14] XING F,LI L,LONG Y,et al. Admission prevalence of
explained’leukocytosis[J]. Am J Med,2020,133(4): deep vein thrombosis in elderly Chinese patients with hip
508-514 fracture and a new predictor based on risk factors for
[9] BRANCHFORD B R,CARPENTER S L. The role of in⁃ thrombosis screening[J]. BMC Musculoskelet Disord,
flammation in venous thromboembolism[J]. Front Pedi⁃ 2018,19(1):444
atr,2018,6:142 [15] KERAMIDAS G,GOURGOULIANIS K I,KOTSIOU O S.
[10] BORGEL D,BIANCHINI E,LASNE D,et al. Inflamma⁃ Venous thromboembolic disease in chronic inflammatory
tion in deep vein thrombosis:a therapeutic target?[J]. He⁃ lung diseases:knowns and unknowns[J]. J Clin Med,
matol Amsterdam Neth,2019,24(1):742-750 2021,10(10):2061
[11] ELMI G,RINALDI E R,DOMANICO A,et al. Calf deep [16] 李亚珍,傅应云,穆雪鹍. 影响急性肺栓塞预后的相关
vein thrombosis ⁃ clinical relevance,diagnostic approaches 因素分析[J]. 南京医科大学学报(自然科学版),2016,
and therapeutic options[J]. VASA,2020,49(5):359-366 36(11):1368-1372
[12] SWIRSKI F K,NAHRENDORF M. Cardioimmunology: [17] KAPTEIN F H J,KROFT L J M,HAMMERSCHLAG G,
the immune system in cardiac homeostasis and disease et al. Pulmonary infarction in acute pulmonary embolism
[J]. Nat Rev Immunol,2018,18(12):733-744 [J]. Thromb Res,2021,202:162-169
[13] BENGOA F,VICENCIO G,SCHWEITZER D,et al. High [18] BUDNIK I,BRILL A. Immune factors in deep vein throm⁃
prevalence of deep vein thrombosis in elderly hip fracture bosis initiation[J]. Trends Immunol,2018,39(8):610-623
patients with delayed hospital admission[J]. Eur J Trau⁃ [收稿日期] 2021-11-12
ma Emerg Surg,2020,46(4):913-917 (本文编辑:陈汐敏)
欢迎关注我刊微博、微信公众号!